Lupin Gets FDA Approval to Market Generic Irbesartan Tablets in US

The US Food and Drug Administration has given approval to Lupin Pharmaceuticals to market its Irbesartan tablets, a generic version of Sanofi Aventis's Avapro, in the country.

The company said that it has received approval to market the Irbesartan tablets in 75-300 mg strengths.

The Avapro tablets are used in treating hypertension and nephropathy in type II diabetic patients and accounted for more than $400.7 million in annual sales, according to data from IMS health.

Source: Medindia